Metformin, a common drug for type 2 diabetes, has shown a surprising effect on metabolism, especially for cancer patients. This video explores a new study revealing how metformin can mimic exercise ...

If you're cutting carbs, upping your protein intake and maybe even taking a medication like metformin, you’re already staying ...

"This study suggests that GLP-1 drugs may offer protective benefits, potentially improving survival and recurrence risk in ...

Patients with breast cancer and metabolic comorbidities have increased risks for cancer recurrence and death. This ...

(Kateryna Kon/Science Photo Library/Getty Images) First, it was named after two men. Then, it was named for a false premise.

Researchers and supporters of the change said the old name, often shortened to PCOS, is inaccurate. It reduced a complex hormonal or endocrine disorder to a misunderstanding about cysts and a focus on ...

Extraordinary survival rates: The study reported up to 91% lower mortality in breast cancer patients with diabetes using GLP-1 drugs compared to insulin or metformin. Data quality concerns: Experts ...

A major new clinical study, SUPER 2, has been published in Nature Communications, reporting that Efsubaglutide Alfa, a ...

A common condition affecting millions of women has a new name.

A hormonal condition impacting one in eight women globally has been given a new name in hopes of improving care ...

Researchers supporting the move said the previous terminology had become medically misleading because it focused heavily on ...

Polycystic ovary syndrome (PCOS) is now known as polyendocrine metabolic ovarian syndrome (PMOS) following a name change ...